-
Mel Ona
Distance: 0.6 Mi13 Oak Pl
02472-3714 Watertown -
Nomir Medical Technologies
Distance: 1.2 Mi307 Waverly Oaks
02452 Waltham -
Jay Fedigan Video
Distance: 1.5 Mi84 Withington Rd
02460-2040 Newtonville -
Susan Rako, M.D
Distance: 1.3 Mi83 Walker St
02460-1519 Newtonville -
Center for Neuroregeneration Research
Distance: 1.9 Mi115 Mill St # I
02478 Belmont
Website Links
Description
GI Dynamics, Inc. (ASX: GID) is the developer of EndoBarrier®, the first endoscopically-delivered device therapy approved for the treatment of type 2 diabetes and/or obesity . EndoBarrier is approved and commercially available in multiple countries outside the U.S. ; and GI Dynamics is conducting a pivotal clinical trial of EndoBarrier ( the ENDO Trial ) in the U.S. for the treatment of patients who have uncontrolled type 2 diabetes and are obese. Founded in 2003, GI Dynamics is headquartered in Lexington, Massachusetts, with offices in Europe and Australia.
GI Dynamics does not sell, trade, or rent your personal data to others. GI Dynamics uses the information you provide to respond to your e-mail, answer your question or resolve your problem. GI Dynamics and our affiliates also use this information to help us improve the content and functionality of our Website, to better understand our customers and markets, and to improve our products and services. GI Dynamics and our affiliates may use this information to contact you in the future to tell you about products or services we believe will be of interest to you.
GI Dynamics' scientific advisors are a prestigious, multidisciplinary group of leaders dedicated to advancing research for the treatment of type 2 diabetes, obesity and metabolic disorders.